Vamorolone does not appear to impair growth in patients with DMD
Scientists compared growth velocities in patients with DMD treated with vamorolone, prednisone, deflazacort, or placebo.
Scientists compared growth velocities in patients with DMD treated with vamorolone, prednisone, deflazacort, or placebo.
Patients who started corticosteroids at a younger age had a lower incidence of depressive symptoms.
The average age at diagnosis was 3.6 years for patients who were ambulatory and 5.6 years for those who were nonambulatory.
Medical records identified mental health concerns in 83.44% of patients from a pediatric DMD clinic.
The DVA 2.0, which includes 18 movement tasks, can assess patients at any disease stage using groups of tasks.